Valuation Boundaries

The equity that belongs to shareholders

At ₹315, Sunteck's ₹4,625.5 crore market value is 1.28 times the ₹3,611.1 crore FY26 equity attributable to shareholders, not 1.03 times the ₹4,472.1 crore headline group equity, because ₹861.1 crore belongs to non-controlling interests. [1] [2] [3]

The counter-fact cuts both ways: ₹315 was 25.9% below the ₹425 warrant price [4], while promoter entities represented 66.5% of proposed capital [5].

The stock also trades at 16.6 times FY27 consensus EPS of ₹18.9806 [6]. A sustained move toward 10% ROE and positive statutory cash flow without higher leverage would improve the range; more estimate cuts would weaken it. Project-level NAV inputs remain unavailable, so book and earnings sensitivities are more honest than a point target.

Sources: market price and FY27 consensus EPS as of 21 July 2026 [7]; FY26 paid-up equity capital and earnings per share [8]; FY26 equity attributable to shareholders [9].

The ₹4,625.5 crore equity value uses 14.6842 crore shares, matching FY26 paid-up capital at ₹1 face value [10]. Sunteck reported ₹4,472.1 crore of total group equity, but only ₹3,611.1 crore was attributable to shareholders; the ₹861.1 crore difference was non-controlling interest [11]. The stock is therefore at 1.03 times total group equity but 1.28 times the book value belonging to common shareholders. The latter is the relevant denominator.

That distinction also changes the growth rate: total group equity rose 37.2% in FY26, while equity attributable to shareholders rose 10.8% [12]; GGICO Sunteck's FY26 reclassification from joint venture to subsidiary makes Dubai consolidation a plausible contributor [13], with the ownership and NCI bridge addressed in Dubai Attribution.

Earnings need a cycle adjustment

Sources: FY19–FY26 reported EPS [14]; FY27–FY28 consensus EPS as of 21 July 2026 [15].

At the current price, the stock is on 22.6 times FY26 EPS, 16.6 times FY27 consensus and 14.0 times FY28 consensus. The three-year average of FY24–FY26 EPS is ₹9.73, which raises the multiple to 32.4 times. This spread is the cost of using completion-led earnings: a single year can be either a trough or a release of prior bookings.

The cash check remains important. FY26 statutory profit after tax was ₹202.1 crore while operating cash flow was negative ₹432.5 crore [16] [17]. The working-capital mechanism is reconciled in Financial Trajectory; for valuation, it means FY26 earnings should not receive a cash-compounder multiple without a reversal in statutory cash flow.

Book value needs a return

Sources: Sunteck [18]; Rustomjee [19]; Oberoi Realty [20]; Lodha [21].

Sunteck’s FY26 ROE improved to 5.6%, above Rustomjee’s 3.3% but well below Oberoi Realty’s 14.0% and Lodha’s 14.7% [22] [23] [24] [25]. These are not identical businesses: Oberoi has more annuity income [26] and Lodha has much greater scale [27]. The comparison is useful only as a return-on-book cross-check, not as a peer fair-value mark.

Two valuation frames

Source: derived from FY26 equity attributable to shareholders and share capital [28] [29], and FY27–FY28 consensus EPS [30]. Multiples are sensitivities, not forecasts.

A 20% haircut to attributable book reduces the 1.0x, 1.25x and 1.5x per-share values from ₹246, ₹307 and ₹369 to ₹197, ₹246 and ₹295, respectively.

The ₹315 market price sits close to 1.25 times FY26 attributable book and 16 times FY27 consensus EPS. The same 16 times applied to FY28 yields ₹360, but that outcome requires the forecast EPS increase to arrive. The range is most sensitive to sustainable ROE and cash conversion, not to published gross development value; Pipeline Economics explains why GDV cannot be used as NAV.

The warrant reference

The September 2025 warrants provide a dated capital-market check. They were offered at ₹425, just 0.4% above the ₹423.31 regulatory floor based on the preceding 90 trading days [31] [32]. The current price is 25.9% lower. This is supportive evidence, but not an independent appraisal: promoter entities proposed to fund 66.5% of the issue [33], and FY26 share capital remained far below the 15.8254 crore shares that full conversion would have produced [34] [35]. The financing context is covered in Promoter Stewardship.

Consensus has moved lower but still assumes growth. FY27 EPS fell 11.7% over 90 days to ₹18.9806, while FY28 fell 16.0% to ₹22.4874 [36]. The relevant monitoring test is specific: attributable ROE moving into double digits, statutory operating cash flow turning positive, and FY27 EPS holding near the current estimate without a material increase in net debt.